Ulcerative Colitis
Ulcerative Colitis (UC) is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon and rectum, leading to symptoms like abdominal pain, diarrhea, and rectal bleeding.
Ulcerative Colitis in Kids: Ozanimod Study
We are testing the oral medication ozanimod in children with moderately to severely active ulcerative colitis who haven't responded to other treatments. The goal is to see if it helps improve their symptoms and overall health.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have moderately to severely active Ulcerative Colitis (UC) diagnosed before this screening?
- Has your Ulcerative Colitis extended beyond the rectum?
- Have you had an inadequate response, loss of response to, or are you intolerant to treatments like oral aminosalicylates, systemic corticosteroids, or biologic therapy?
- Do you have Crohn's disease or indeterminate colitis?
- Have you had a positive test for Clostridium difficile in the past?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Brussel
Pediatric gastroenterology
Ganshoren, Belgium
UZ Leuven
Pediatric gastroenterology
Heverlee, Belgium
Centre Hospitalier Regional De La Citadelle
Pediatric gastroenterology
Liège, Belgium
Sponsor: Bristol-Myers Squibb Services Unlimited Company
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.